# Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus

> **NCT05700513** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tabriz University of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **COMBINATION_PRODUCT:** Capsules containing the combination products
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT05700513
- **Lead sponsor:** Tabriz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-28
- **Primary completion:** 2024-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05700513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05700513, "Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05700513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*